Clinical trial Recruiting at 1 site Interventional Ages 18 to 90

Comparing blood-flow restricted exercise to traditional exercise for COPD patients

Official title: The Acute Cardiorespiratory Response to Blood-flow Restricted Versus Traditional Exercise Training Regimens (CaRe BFR):4 Randomized Crossover Studies

Run by University of Zurich · NCT05163600 · Data updated 2026-11-12

This study tests if exercising with blood-flow restriction can help people with COPD improve their strength and breathing better than traditional exercise.

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment24 (estimated)
SponsorUniversity of Zurich
Academic / other
Locations1 site (Zurich, Canton of Zurich)
StatusRecruiting
StartedMay 20, 2022
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedJuly 7, 2026
Trial IDNCT05163600 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older diagnosed with COPD according to GOLD guidelines.

Probably not a fit

Patients with acute exacerbations of COPD or those with physical impairments that prevent participation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the acute cardiorespiratory responses to blood-flow restricted (BFR) exercise compared to traditional exercise regimens in both healthy individuals and those with Chronic Obstructive Pulmonary Disease (COPD). Participants will engage in strength training using a Leg Press machine, with specific methodologies designed to enhance muscle strength. The study employs a randomized crossover design to assess differences in exercise responses and blood pressure levels between the two training approaches. The goal is to determine if BFR training offers distinct advantages for individuals with COPD.

Why it matters

Potential benefit: If successful, this study could provide insights into more effective exercise regimens for improving the health and quality of life for COPD patients.

How similar studies have gone: Previous studies have shown promising results with blood-flow restricted training, suggesting potential benefits for muscle strength and cardiovascular responses.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion and exclusion for the healthy participants are defined by the following criteria.

Inclusion criteria:

* Age ≥ 18 years
* Clinically healthy

Exclusion criteria:

* Physical or intellectual impairment precluding informed consent or protocol adherence
* Non-German speaking (precluding informed consent)
* Pain during exercise of any origin
* Pregnancy
* History of thromboembolic event in the lower extremity
* Resting systolic blood pressure \<100 mmHg

Inclusion and exclusion for the COPD participants are defined by the following criteria.

Inclusion criteria:

* Age ≥ 18 years
* Diagnosed COPD according to GOLD-guidelines12

Exclusion criteria:

* Physical or intellectual impairment precluding informed consent or protocol adherence
* Non-German speaking (precluding informed consent)
* Acute or recent (within the last 6 weeks) exacerbation of COPD
* Pain during exercise of any origin
* Pregnancy
* History of thromboembolic event in the lower extremity
* Resting systolic blood pressure \<100 mmHg

Where it's running

  • University Hospital Zürich
    Zurich, Canton of Zurich, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer

    This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.

    Recruiting Phase 2 AeroRx Therapeutics Inc. · London and 1 other locations · NCT07896252

  • Cognitive load and inhaler technique in COPD

    This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.

    Recruiting Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie Dr. Victor Babeș Timișoara · Timișoara, Timiș County · NCT07786220

  • Balance training after pulmonary rehab for COPD to help steadiness and reduce falls

    A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.

    Recruiting at 3 sites Teesside University · Middlesbrough and 2 other locations · NCT07750821

  • Continuous vs High-Intensity Interval Exercise in COPD

    This study tests whether continuous versus high-intensity interval exercise affects cerebral oxygenation in people with COPD.

    Recruiting George Papanicolaou Hospital · Thessaloniki, Exohi · NCT07707271

  • Biomarker clues for COPD, IPF, and lung cancer

    This study tests whether inflammation, immune, genetic, and epigenetic markers at enrollment can explain how COPD, IPF, or lung cancer present and behave, in order to see if these markers can predict outcomes over a year.

    Recruiting Fondazione Don Carlo Gnocchi ETS · Milan, Milan · NCT07707245

  • HRS-9821 Inhalation Suspension for COPD: Safety and Dose Finding in Adults

    This study tests whether HRS-9821 inhalation can be safely taken and help people with moderate to severe COPD, and aims to find a reasonable dose.

    Recruiting Phase 2 Guangdong Hengrui Pharmaceutical Co., Ltd · Shanghai, Shanghai Municipality · NCT07640451

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.